Unusual treatment of Kasabach-Merritt syndrome secondary to hepatic hemangioma: embolization with bleomycin

dc.contributor.authorBozkaya, Halil
dc.contributor.authorCinar, Celal
dc.contributor.authorUnalp, Omer Vedat
dc.contributor.authorParildar, Mustafa
dc.contributor.authorOran, Ismail
dc.date.accessioned2019-10-27T22:59:59Z
dc.date.available2019-10-27T22:59:59Z
dc.date.issued2015
dc.departmentEge Üniversitesien_US
dc.description.abstractKasabach-Merritt syndrome (KMS) is a rare complication of cavernous hemangiomas characterized with anemia, thrombocytopenia, and consumption coagulopathy. This syndrome usually develops due to superficial soft tissue hemangiomas in infancy and childhood. KMS developing secondarily to hepatic hemangioma is very rare. In this report, we aimed to present the treatment of KMS developing secondarily to giant cavernous hemangioma of the liver with transarterial chemoembolization using bleomycin.en_US
dc.identifier.doi10.1007/s00508-014-0675-5en_US
dc.identifier.endpage490en_US
dc.identifier.issn0043-5325
dc.identifier.issn1613-7671
dc.identifier.issue11.Decen_US
dc.identifier.pmid25471004en_US
dc.identifier.startpage488en_US
dc.identifier.urihttps://doi.org/10.1007/s00508-014-0675-5
dc.identifier.urihttps://hdl.handle.net/11454/51922
dc.identifier.volume127en_US
dc.identifier.wosWOS:000356802200012en_US
dc.identifier.wosqualityQ3en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakPubMeden_US
dc.language.isoenen_US
dc.publisherSpringer Wienen_US
dc.relation.ispartofWiener Klinische Wochenschriften_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectKasabach-Merritt syndromeen_US
dc.subjectLiver hemangiomasen_US
dc.subjectTransarterial chemoembolizationen_US
dc.subjectBleomycinen_US
dc.subjectLipiodolen_US
dc.titleUnusual treatment of Kasabach-Merritt syndrome secondary to hepatic hemangioma: embolization with bleomycinen_US
dc.typeArticleen_US

Dosyalar